MaxWell Biosystems
MaxWell Biosystems AG provides high-content electrophysiology platforms that advance scientific discovery and accelerate drug discovery for neurodegenerative diseases. The company was founded in September 2016 as an ETH Zürich spin-off with its first product, MaxOne, a high-density microelectrode (HD-MEA) system used by academic and research laboratories to investigate the activity of cells in vitro at network, cellular, and subcellular levels. The launch of MaxTwo, a multi-well HD-MEA platform, increases the throughput of performing cell-based assays to 6- and 24-well plates catering to pharmaceutical and biotech companies, as well as contract research organizations. MaxWell Biosystems is a leading expert, both on the technology to develop hardware and software, as well as on the scientific applications of HD-MEAs.
About MaxWell Biosystems
Founded
2016Estimated Revenue
$1M-$10MEmployees
11-50Category
Industry
BiotechnologyLocation
City
ZürichState
ZurichCountry
SwitzerlandTech Stack (84)
Analytics and Tracking
Widgets
Bookly
WPML Multilingual
Ultimate Social Media
Zoom Video Conferencing
follow.it
Slack
MonsterInsights
Font Awesome
Jetpack
Gravatar Profiles
Wordpress Plugins
Pinterest
Easy Twitter Feed Widget Plugin
Column Shortcodes
Twemoji
Google Font API
Contact Form 7
TablePress
Sitelinks Search Box
Easy Bootstrap Shortcode
Smush Image Optimization
WP Google Maps
Calendly
Google Tag Manager
CookieYes for WordPress
TLP Team
Redirection for Contact Form 7
AMO Team Showcase
CPO Widgets
Video Embed and Thumbnail Generator
WP Fastest Cache
WP Super Minify
US Privacy User Signal Mechanism
CrUX Dataset
PDFjs Viewer for Wordpress
WP Content Copy Protection
Yoast Plugins
Azure Active Directory